Morning Briefing
Summaries of health policy coverage from major news organizations
Drug Company Fights For Patent Extension
In a gaffe that could cost it millions of dollars, the drug maker Medicines Company, which makes the blood thinner called Angiomax, missed the application deadline to extend its patent back in 2000 by a day or two. That patent expires on Tuesday.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
